PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2084822
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2084822
Blood Group Typing Market is estimated to be valued at USD 2,185.7 Mn in 2026 and is expected to reach USD 3,612.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2,185.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.40% | 2033 Value Projection: | USD 3,612.8 Mn |
The global blood group typing market is the major part of the clinical diagnostics market and consists of products and technologies used in blood group identification, compatibility testing for blood and organ transplants and prenatal testing. The blood group typing market is based on ABO and Rh blood grouping typing techniques with extended additional blood group testing for transfusion transmitted infections. The system and reagents are used for blood grouping testing in hospitals, laboratories, diagnostics and blood banks.
The growing need for safe blood transfusions along with increasing number of surgical procedures and rising prevalence of chronic diseases that require constant blood support are contributing towards the market growth. In addition, technological upgradations like automated immunohematology analyzers, molecular blood typing, and high throughput testing platforms are improving the accuracy of testing processes and operational efficiencies. Moreover, growing blood donation drives, improved healthcare infrastructure and strict regulatory mandates on blood safety standards are further expanding the deployment of blood group typing solutions across the globe.
The global blood group typing market is driven by the increasing need for safe blood transfusions, increasing number of surgeries being performed and growing incidence of chronic diseases including cancer, kidney diseases and blood related illnesses that are indication for multiple blood transfusions. Growing importance of blood safety and aging population are also supplementing the market growth. Other factors that are expected to drive this market include specifications of advanced automated immunohematology analyzers, molecular typing approaches, and point-of-care testing solutions.
However, a number of constraints are present in the market, such as high-priced modern blood typing techniques, regulatory hurdles and requirement of trained person to operate sophisticated diagnostic machines. Nevertheless, emerging opportunities are seen from rising healthcare infrastructure in emerging economies, rising investments in blood banks and rising use of automation in laboratories. Improved workflow Automation with the integration of artificial intelligence and digital diagnostics in transfusion medicine is also seen to bring opportunities.